Regulation of Cathepsin G Reduces the Activation of Proinsulin-Reactive T Cells from Type 1 Diabetes Patients

Processing and presentation of (pro)-insulin in the MHC class II pathway: the generation of antigen-based immunomodulators in the context of type 1 diabetes mellitus

(2010) Timo Burster et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

How Immune Peptidases Change Specificity: Cathepsin G Gained Tryptic Function but Lost Efficiency during Primate Evolution

(2010) W. W. Raymond et al.   JOURNAL OF IMMUNOLOGY

Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouse

(2009) Lianne C. Hsing et al.   JOURNAL OF AUTOIMMUNITY

Identification of Human Cathepsin G As a Functional Target of Boswellic Acids from the Anti-Inflammatory Remedy Frankincense

(2009) L. Tausch et al.   JOURNAL OF IMMUNOLOGY

1,25-Dihydroxyvitamin D3 and IL-2 Combine to Inhibit T Cell Production of Inflammatory Cytokines and Promote Development of Regulatory T Cells Expressing CTLA-4 and FoxP3

(2009) L. E. Jeffery et al.   JOURNAL OF IMMUNOLOGY

Application of specific cell permeable cathepsin G inhibitors resulted in reduced antigen processing in primary dendritic cells

(2009) Michael Reich et al.   MOLECULAR IMMUNOLOGY

Cathepsin G: Roles in antigen presentation and beyond

(2009) Timo Burster et al.   MOLECULAR IMMUNOLOGY

Dual inhibition of proteasomal and lysosomal proteolysis ameliorates autoimmune central nervous system inflammation

(2008) Nicolas Fissolo et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Curative and   cell regenerative effects of  1-antitrypsin treatment in autoimmune diabetic NOD mice

(2008) M. Koulmanda et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA